Skip to main content
OpenTrials
Completed

NCT Number: NCT03416920

A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk

The investigators aim to evaluate Wellframe, a patient engagement platform that includes a mobile phone application for patients, for its impact on supporting patients who have undergone a percutaneous coronary intervention. The patient mobile app has articles about cardiovascular disease and other health related topics, patient-reported outcomes surveys, physical activity tracking, reminders for medications and upcoming appointments, and two-way communication with a Wellframe Health Advocate. The Wellframe Health Advocate encourages patients to achieve their health goals and stay engaged in their health. The feasibility of onboarding patients to the app and the clinical efficacy of the platform will be evaluated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Percutaneous Coronary Intervention

Age range

21 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brigham and Women's Hospital, Boston, Massachusetts, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

English-speaking PCI: balloon angioplasty, bare-metal stent, or drug-eluting stent at MGH Smartphone or Tablet (iOS or Android)

Exclusion criteria

Recent (within 1mo) illicit substance use or alcohol abuse In-hospital AMI Known pregnancy Dementia or cognitive disability Incarceration

Treatment and study plan

Wellframe

Other

Wellframe mobile phone app

Primary outcomes

  1. Number of Participants With Readmission at 30 Days

    Time frame: 30 Days

    How many subjects were readmitted to the hospital

Secondary outcomes

  1. Number of Participants With Readmission at 90 Days

    Time frame: 90 Days

    How many subjects were readmitted to the hospital

  2. Number of Participants Enrolled in Clinic-based Cardiac Rehab at 90 Days

    Time frame: 90 days

    Percent of patients discharged after intervention who attend at least one session of clinic-based cardiac rehab

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Collaborators

  • Boston Scientific Corporation
  • Wellframe, Inc.

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jan 31, 2018
Registry last updated
Jul 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.